Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Broggi

Showing results (811-820 of 888) with videos related to

Pageof 89
Sort By:
Cell Death & Disease|October 18, 2023
MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromesC Giallongo, I Dulcamare, S Giallongo, et al.
Oncoimmunology|September 18, 2018
Lymphatic vessel density is associated with CD8Natacha Bordry, Maria A S Broggi, Kaat de Jonge, et al.
Physics and Imaging in Radiation Oncology|March 11, 2026
Multicentre dosimetry audit in the European randomized phase III study of neoadjuvant chemoradiotherapy using proton versus photon radiotherapy in locally advanced oesophageal cancerMai L Ehmsen, Camilla S Byskov, Hanna R Mortensen, et al.
Cell|September 7, 2021
The interferon landscape along the respiratory tract impacts the severity of COVID-19Benedetta Sposito, Achille Broggi, Laura Pandolfi, et al.
Plos Pathogens|July 31, 2018
Intersection of phosphate transport, oxidative stress and TOR signalling in Candida albicans virulenceNing-Ning Liu, Priya Uppuluri, Achille Broggi, et al.
Cancers|September 13, 2025
Metastatic Carcinomas at the Episiotomy Site: A Systematic Literature ReviewAndrea Palicelli, Gabriele Tonni, Federica Torricelli, et al.
Journal for Immunotherapy of Cancer|August 4, 2025
An affinity-modulated T cell engager targeting Claudin 18.2 shows potent anti-tumor activity with limited cytokine releaseMiguel Gaspar, Marina Natoli, Laure Castan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2024
Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal CancersAllison M Barrett, Zachary T Britton, Rosa A Carrasco, et al.
Breast (Edinburgh, Scotland)|December 16, 2020
Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized?Andrei Fodor, Chiara Brombin, Paola Mangili, et al.
Nature Immunology|September 30, 2025
Plasmacytoid dendritic cells are dispensable or detrimental in murine systemic or respiratory viral infectionsClemence Ngo, Camille Pierini-Malosse, Khalissa Rahmani, et al.
Pageof 89

Showing results (811-820 of 888) with videos related to

Sort By:
Pageof 89
Cell Death & Disease|October 18, 2023
MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromesC Giallongo, I Dulcamare, S Giallongo, et al.
Oncoimmunology|September 18, 2018
Lymphatic vessel density is associated with CD8Natacha Bordry, Maria A S Broggi, Kaat de Jonge, et al.
Physics and Imaging in Radiation Oncology|March 11, 2026
Multicentre dosimetry audit in the European randomized phase III study of neoadjuvant chemoradiotherapy using proton versus photon radiotherapy in locally advanced oesophageal cancerMai L Ehmsen, Camilla S Byskov, Hanna R Mortensen, et al.
Cell|September 7, 2021
The interferon landscape along the respiratory tract impacts the severity of COVID-19Benedetta Sposito, Achille Broggi, Laura Pandolfi, et al.
Plos Pathogens|July 31, 2018
Intersection of phosphate transport, oxidative stress and TOR signalling in Candida albicans virulenceNing-Ning Liu, Priya Uppuluri, Achille Broggi, et al.
Cancers|September 13, 2025
Metastatic Carcinomas at the Episiotomy Site: A Systematic Literature ReviewAndrea Palicelli, Gabriele Tonni, Federica Torricelli, et al.
Journal for Immunotherapy of Cancer|August 4, 2025
An affinity-modulated T cell engager targeting Claudin 18.2 shows potent anti-tumor activity with limited cytokine releaseMiguel Gaspar, Marina Natoli, Laure Castan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2024
Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal CancersAllison M Barrett, Zachary T Britton, Rosa A Carrasco, et al.
Breast (Edinburgh, Scotland)|December 16, 2020
Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized?Andrei Fodor, Chiara Brombin, Paola Mangili, et al.
Nature Immunology|September 30, 2025
Plasmacytoid dendritic cells are dispensable or detrimental in murine systemic or respiratory viral infectionsClemence Ngo, Camille Pierini-Malosse, Khalissa Rahmani, et al.
Pageof 89